Diarmuid Flavin
Geschäftsführer bei Neuromod Devices Ltd.
Profil
Diarmuid Flavin is currently the Chief Operating Officer at Neuromod Devices Ltd.
He previously worked as the Chief Executive Officer at Biosensia Ltd.
from 2011 to 2013.
Before that, he held positions at Bioniche, Inc., Abbott Vascular Devices, and ArcRoyal Unlimited Co. Mr. Flavin graduated from Trinity College Dublin with a graduate degree and from the National University of Ireland with both an undergraduate and graduate degree.
Aktive Positionen von Diarmuid Flavin
| Unternehmen | Position | Beginn |
|---|---|---|
Neuromod Devices Ltd.
 Neuromod Devices Ltd. Medical SpecialtiesHealth Technology Neuromod Devices Ltd. operates as a medical device company which engages in the research and development of neuromodulation technologies for chronic tinnitus. The firm develops proprietary neuromodulation technologies designed to address pathologies, which are believed to give rise to illusory perceptions, such as tinnitus. These technologies utilize bi-modal neuromodulation and aim to promote positive therapeutic change within the human nervous system. The company was founded by Ross O?Neill in 2010 and is headquartered in Dublin, Ireland. | Geschäftsführer | 30.08.2021 |
Ehemalige bekannte Positionen von Diarmuid Flavin
| Unternehmen | Position | Ende |
|---|---|---|
Biosensia Ltd.
 Biosensia Ltd. Packaged SoftwareTechnology Services Biosensia Ltd. develops multiplexing point of care in vitro diagnostics platform. It offers RapiPlex, a point-of-care diagnosis system based on a set of proprietary technologies capable of producing quantitative and qualitative laboratory quality test results. The company was founded by Gareth Redmond and Gabriel Crean in 2009 and is headquartered in Dublin, Ireland. | Präsident | 19.02.2013 |
| ArcRoyal Unlimited Co. | Corporate Officer/Principal | - |
| Bioniche, Inc. | Corporate Officer/Principal | - |
Abbott Vascular Devices
 Abbott Vascular Devices Medical SpecialtiesHealth Technology Part of Abbott Laboratories, Abbott Vascular Devices develops and manufactures cardiovascular devices for people with cardiovascular disease. The company is based in Redwood City, CA. | Geschäftsführer | - |
Ausbildung von Diarmuid Flavin
| Trinity College Dublin | Graduate Degree |
| National University of Ireland | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
| Bioniche, Inc. | Health Technology |
Abbott Vascular Devices
Abbott Vascular Devices Medical SpecialtiesHealth Technology Part of Abbott Laboratories, Abbott Vascular Devices develops and manufactures cardiovascular devices for people with cardiovascular disease. The company is based in Redwood City, CA. | Health Technology |
Biosensia Ltd.
Biosensia Ltd. Packaged SoftwareTechnology Services Biosensia Ltd. develops multiplexing point of care in vitro diagnostics platform. It offers RapiPlex, a point-of-care diagnosis system based on a set of proprietary technologies capable of producing quantitative and qualitative laboratory quality test results. The company was founded by Gareth Redmond and Gabriel Crean in 2009 and is headquartered in Dublin, Ireland. | Technology Services |
| ArcRoyal Unlimited Co. | |
Neuromod Devices Ltd.
Neuromod Devices Ltd. Medical SpecialtiesHealth Technology Neuromod Devices Ltd. operates as a medical device company which engages in the research and development of neuromodulation technologies for chronic tinnitus. The firm develops proprietary neuromodulation technologies designed to address pathologies, which are believed to give rise to illusory perceptions, such as tinnitus. These technologies utilize bi-modal neuromodulation and aim to promote positive therapeutic change within the human nervous system. The company was founded by Ross O?Neill in 2010 and is headquartered in Dublin, Ireland. | Health Technology |
